Retinal Cell and Gene Therapy Innovation Summit Congress ProQR to present at the Retinal Cell and Gene Therapy Innovation Summit. April 29, 2022
ProQR Announces R&D Day and Provides Update on Innovation Portfolio Press release First Investor R&D Day on March 14, 2016 in New York, NY November 30, 2015
ProQR Receives € 4.7 million in Innovation Credit from Dutch Government for QR-110 for LCA10 Press release LEIDEN, Netherlands and CAMBRIDGE, Mass., Dec. 10, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. December 10, 2018
ProQR to Present at the Retinal Cell and Gene Therapy Innovation Summit and the Association for Research in Vision and Ophthalmology (ARVO) 2022 Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., April 26, 2022 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. April 26, 2022
RNA Leaders Europe Congress Presentation ProQR Presentation at RNA Leaders Europe Congress March 16, 2023
Oligonucleotide and Precision Therapeutics (OPT) Congress Congress ProQR presentation and panel session at the Oligonucleotide and Precision Therapeutics (OPT) Congress March 14, 2023
Fall Eye on the Future Forum (EFF) Summit 2020 Virtual Congress The EFF is a growing multiple stakeholder platform for the exchange and sharing of insights and innovations to drive the future of clinical development in inherited retinal diseases. Organized by ProQR September 23, 2020
ProQR Analyst Event Webcast During this webcast ProQR leadership will highlight key advancements from its clinical-stage pipeline and Axiomer® RNA editing platform. November 18, 2021
ProQR Announces Results for the Second Quarter of 2015 Press release LEIDEN, the Netherlands, Aug. 19, 2015 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. August 19, 2015